Hypertension
Authors: Christine Laine
Journal: Annals of Internal Medicine (2008)

In the Clinic2 December 2008HypertensionChristine Laine, MD, MPH, David R. Goldman, MD, Harold C. Sox, MD, Debbie L. Cohen, MD, and Raymond R. Townsend, MDChristine Laine, MD, MPHSearch for more papers by this author, David R. Goldman, MDSearch for more papers by this author, Harold C. Sox, MDSearch for more papers by this author, Debbie L. Cohen, MDSearch for more papers by this author, and Raymond R. Townsend, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-149-11-200812020-01006 SectionsSupplemental MaterialAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Editor's Note: This issue of In the Clinic has been updated.Screening and PreventionHypertension affects more than 65 million people in the United States, with about 2 million new cases diagnosed annually (1, 2). Most patients have primary or essential hypertension and are likely to remain hypertensive for life. Risk factors for hypertension include a family history of hypertension, African-American ethnicity, obesity, a high sodium or alcohol intake, and a sedentary lifestyle. Treatment to control blood pressure level reduces the risk for cardiovascular, cerebrovascular, and renal outcomes of hypertension. Unfortunately, many people with hypertension do not receive optimal therapy.... References1. Ong KL, Cheung BM, Man YB, et al. Prevalence, awareness, treatment, and control of hypertension among United States adults 1999-2004. Hypertension. 2007;49:69-75. [PMID: 17159087] Google Scholar2. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung, and Blood Institute. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52. [PMID: 14656957] Google Scholar3. U.S. Preventive Services Task Force. Screening for high blood pressure: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann Intern Med. 2007;147:783-6. [PMID: 18056662] Google Scholar4. Julius S, Nesbitt SD, Egan BM, et al. Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med. 2006;354:1685-97. [PMID: 16537662] Google Scholar5. Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334(7599):885. Google Scholar6. Batey DM, Kaufmann PG, Raczynski JM, et al. Stress management intervention for primary prevention of hypertension: detailed results from Phase I of Trials of Hypertension Prevention (TOHP-I). Ann Epidemiol. 2000;10(1):45-58. Google Scholar7. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1. Circulation. 2005;111:697-716. [PMID: 15699287] Google Scholar8. Messerli FH. Osler's maneuver, pseudohypertension, and true hypertension in the elderly. Am J Med. 1986;80:906-10. [PMID: 2939716] Google Scholar9. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368-74. [PMID: 16738273] Google Scholar10. Angeli F, Verdecchia P, Gattobigio R, et al. White-coat hypertension in adults. Blood Press Monit. 2005;10:301-5. [PMID: 16496443] Google Scholar11. Eguchi K, Hoshide S, Ishikawa J, et al. Cardiovascular prognosis of sustained and white-coat hypertension in patients with type 2 diabetes mellitus. Blood Press Monit. 2008;13:15-20. [PMID: 18199919] Google Scholar12. Cicconetti P, Morelli S, De Serra C, et al. Left ventricular mass in dippers and nondippers with newly diagnosed hypertension. Angiology. 2003;54:661-9. [PMID: 14666954] Google Scholar13. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401-6. [PMID: 12642361] Google Scholar14. Fierro-Carrion GA, Ram CV. Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure [Editorial]. Am J Cardiol. 1997;80:775-6. [PMID: 9315588] Google Scholar15. Cordain L, Eaton SB, Sebastian A, et al. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr. 2005;81:341-54. [PMID: 15699220] Google Scholar16. Mattes RD, Donnelly D. Relative contributions of dietary sodium sources. J Am Coll Nutr. 1991;10:383-93. [PMID: 1910064] Google Scholar17. Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med. 1997;336:1117-24. [PMID: 9099655] Google Scholar18. Bray GA, Vollmer WM, Sacks FM, et al. A further subgroup analysis of the effects of the DASH diet and three dietary sodium levels on blood pressure: results of the DASH-Sodium Trial. Am J Cardiol. 2004;94:222-7. [PMID: 15246908] Google Scholar19. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998;279:839-46. [PMID: 9515998] Google Scholar20. Xin X, He J, Frontini MG, et al. Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2001;38:1112-7. [PMID: 11711507] Google Scholar21. Fagrell B, De Faire U, Bondy S, et al. The effects of light to moderate drinking on cardiovascular diseases. J Intern Med. 1999;246:331-40. [PMID: 10583704] Google Scholar22. McGuire HL, Svetkey LP, Harsha DW, et al. Comprehensive lifestyle modification and blood pressure control: a review of the PREMIER trial. J Clin Hypertens (Greenwich). 2004;6:383-90. Google Scholar23. Alexander CN, Schneider RH, Staggers F, et al. Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis. Hypertension. 1996;28:228-37. [PMID: 8707387] Google Scholar24. Taubert D, Roesen R, Schömig E. Effect of cocoa and tea intake on blood pressure: a meta-analysis. Arch Intern Med. 2007;167:626-34. [PMID: 17420419] Google Scholar25. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone. ALLHAT Collaborative Research Group. JAMA 2000;283:1967-75. [PMID: 10789664] Google Scholar26. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-98. [PMID: 18378519] Google Scholar27. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:145-53. [PMID: 10639539] Google Scholar28. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895-906. [PMID: 16154016] Google Scholar29. ONTARGET Investigators. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547-59. [PMID: 18378520] Google Scholar30. Phillips LS, Branch WT, Cook CB, et al. Clinical inertia. Ann Intern Med. 2001;135:825-34. [PMID: 11694107] Google Scholar31. Moser M, Setaro JF. Clinical practice. Resistant or difficult-to-control hypertension. N Engl J Med. 2006;355:385-92. [PMID: 16870917] Google Scholar32. American Heart Association Professional Education Committee. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation. 2008;117:e510-26. [PMID: 18574054] Google Scholar33. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996;9:1-11. [PMID: 8834700] Google Scholar34. Wilson MD, Johnson KA. Hypertension management in managed care: the role of home blood pressure monitoring. Blood Press Monit. 1997;2:201-206. [PMID: 10234118] Google Scholar35. Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:1-9. [PMID: 18497371] Google Scholar36. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139-85. [PMID: 14973512] Google Scholar37. Townsend R. Hypertensive crisis. In: Lanken PN, ed. The Intensive Care Unit Manual. Vol. 2000. Philadelphia: WB Saunders; 2000:602-14. Google Scholar38. Lip GY, Beevers M, Beevers DG. Complications and survival of 315 patients with malignant-phase hypertension. J Hypertens. 1995;13:915-24. [PMID: 8557970] Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoCorrection: In The Clinic: Hypertension Metrics 2 December 2008Volume 149, Issue 11Page: ITC6-1KeywordsACE inhibitorsBlood pressureCardiovascular diseasesDietDiureticsDrugsHypertensionMyocardial infarctionSodiumSystolic pressure ePublished: 2 December 2008 Issue Published: 2 December 2008 Copyright & PermissionsCopyright © 2008 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...